• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟员工重复无症状检测策略对 SARS-CoV-2 传播潜力的影响。

Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential.

机构信息

Department of Mathematics, University of Manchester, United Kingdom.

Department of Mathematics, University of Manchester, United Kingdom.

出版信息

J Theor Biol. 2023 Jan 21;557:111335. doi: 10.1016/j.jtbi.2022.111335. Epub 2022 Nov 2.

DOI:10.1016/j.jtbi.2022.111335
PMID:36334850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9626407/
Abstract

Repeat asymptomatic testing in order to identify and quarantine infectious individuals has become a widely-used intervention to control SARS-CoV-2 transmission. In some workplaces, and in particular health and social care settings with vulnerable patients, regular asymptomatic testing has been deployed to staff to reduce the likelihood of workplace outbreaks. We have developed a model based on data available in the literature to predict the potential impact of repeat asymptomatic testing on SARS-CoV-2 transmission. The results highlight features that are important to consider when modelling testing interventions, including population heterogeneity of infectiousness and correlation with test-positive probability, as well as adherence behaviours in response to policy. Furthermore, the model based on the reduction in transmission potential presented here can be used to parameterise existing epidemiological models without them having to explicitly simulate the testing process. Overall, we find that even with different model paramterisations, in theory, regular asymptomatic testing is likely to be a highly effective measure to reduce transmission in workplaces, subject to adherence. This manuscript was submitted as part of a theme issue on "Modelling COVID-19 and Preparedness for Future Pandemics".

摘要

为了识别和隔离具有传染性的个体,重复进行无症状检测已成为广泛使用的控制 SARS-CoV-2 传播的干预措施。在某些工作场所,特别是在有易感患者的卫生和社会保健环境中,定期对工作人员进行无症状检测,以降低工作场所暴发的可能性。我们根据文献中可用的数据开发了一个模型,以预测重复无症状检测对 SARS-CoV-2 传播的潜在影响。结果突出了在建模检测干预措施时需要考虑的特征,包括传染性的人群异质性和与检测阳性概率的相关性,以及对政策的遵守行为。此外,本文基于提出的传播潜力降低的模型,可以用来参数化现有的流行病学模型,而无需明确模拟检测过程。总体而言,我们发现,即使在不同的模型参数化条件下,从理论上讲,定期进行无症状检测很可能是一种非常有效的措施,可以降低工作场所的传播,前提是要遵守规定。本文作为关于“COVID-19 建模和为未来大流行做准备”主题特刊的一部分提交。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/a9519000586f/gr14_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/11ec05f71b32/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/d5c827ec60bf/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/64e7270c18fd/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/e35328c757dd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/5be2c10b3af7/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/a3a2d07223d3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/f0d0f515b5b0/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/25a1dd707aa5/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/1d56f00a6a3b/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/dc743946e33a/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/843d81ceb13c/gr11_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/12f21308f13e/gr12_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/e854c198c762/gr13_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/a9519000586f/gr14_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/11ec05f71b32/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/d5c827ec60bf/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/64e7270c18fd/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/e35328c757dd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/5be2c10b3af7/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/a3a2d07223d3/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/f0d0f515b5b0/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/25a1dd707aa5/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/1d56f00a6a3b/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/dc743946e33a/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/843d81ceb13c/gr11_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/12f21308f13e/gr12_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/e854c198c762/gr13_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b087/9626407/a9519000586f/gr14_lrg.jpg

相似文献

1
Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential.模拟员工重复无症状检测策略对 SARS-CoV-2 传播潜力的影响。
J Theor Biol. 2023 Jan 21;557:111335. doi: 10.1016/j.jtbi.2022.111335. Epub 2022 Nov 2.
2
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sector.模拟非药物干预措施对家庭配送行业中SARS-CoV-2在工作场所传播的影响。
PLoS One. 2023 May 5;18(5):e0284805. doi: 10.1371/journal.pone.0284805. eCollection 2023.
3
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
4
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
5
Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.对小学生模拟人群进行 SARS-CoV-2 诊断检测、筛查和监测策略的估计传播结果和成本。
JAMA Pediatr. 2022 Jul 1;176(7):679-689. doi: 10.1001/jamapediatrics.2022.1326.
6
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.比较 COVID-19 控制的分子检测策略:一项数学建模研究。
Lancet Infect Dis. 2020 Dec;20(12):1381-1389. doi: 10.1016/S1473-3099(20)30630-7. Epub 2020 Aug 18.
7
A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2.一种评估工人群体中非药物疾病控制措施的网络建模方法:在 SARS-CoV-2 中的应用。
PLoS Comput Biol. 2021 Jun 16;17(6):e1009058. doi: 10.1371/journal.pcbi.1009058. eCollection 2021 Jun.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
10
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.

引用本文的文献

1
Effectiveness and user experience of nose and throat swabbing techniques for SARS-CoV-2 detection: results from the UK COVID-19 National Testing Programme.用于检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的鼻咽拭子采样技术的有效性和用户体验:英国2019冠状病毒病国家检测计划的结果
BMC Glob Public Health. 2025 Jan 13;3(1):5. doi: 10.1186/s44263-024-00121-x.
2
Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies.通过 SARS-CoV-2 检测技术的结合,更快地发现英国护理院工作人员中的无症状 COVID-19 病例。
Sci Rep. 2024 Mar 29;14(1):7475. doi: 10.1038/s41598-024-57817-1.
3

本文引用的文献

1
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort.Sars-Cov-2 抗原检测基于病毒培养预测传染性:对大样本队列的抗原、PCR 病毒载量和病毒培养检测的比较。
Clin Microbiol Infect. 2023 Jan;29(1):94-100. doi: 10.1016/j.cmi.2022.07.010. Epub 2022 Jul 19.
2
Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant.BA.1 奥密克戎变异株感染的潜伏期更短。
Int J Environ Res Public Health. 2022 May 23;19(10):6330. doi: 10.3390/ijerph19106330.
3
Heterogeneity in testing for infectious diseases.
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.
分析病毒爆发的风险和先发制人的控制:以 SARS-CoV-2 为例,考虑到宿主内动力学。
Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2305451120. doi: 10.1073/pnas.2305451120. Epub 2023 Oct 3.
4
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sector.模拟非药物干预措施对家庭配送行业中SARS-CoV-2在工作场所传播的影响。
PLoS One. 2023 May 5;18(5):e0284805. doi: 10.1371/journal.pone.0284805. eCollection 2023.
5
Pandemic Preparedness among Big Energy Companies: Call to Research and Action.大能源公司的大流行准备:研究和行动的呼吁。
Int J Environ Res Public Health. 2023 Feb 4;20(4):2771. doi: 10.3390/ijerph20042771.
传染病检测中的异质性。
R Soc Open Sci. 2022 May 18;9(5):220129. doi: 10.1098/rsos.220129. eCollection 2022 May.
4
Testing and Isolation Efficacy: Insights from a Simple Epidemic Model.测试和隔离效果:来自简单传染病模型的见解。
Bull Math Biol. 2022 May 13;84(6):66. doi: 10.1007/s11538-022-01018-2.
5
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.每日纵向采样 SARS-CoV-2 感染揭示了传染性的显著异质性。
Nat Microbiol. 2022 May;7(5):640-652. doi: 10.1038/s41564-022-01105-z. Epub 2022 Apr 28.
6
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.奥密克戎变异株的二次感染率、传播和潜伏期以及间隔时间,西班牙。
Emerg Infect Dis. 2022 Jun;28(6):1224-1228. doi: 10.3201/eid2806.220158. Epub 2022 Apr 7.
7
Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study.非药物干预措施对英国养老院中 SARS-CoV-2 爆发的影响:一项建模研究。
BMC Infect Dis. 2022 Apr 1;22(1):324. doi: 10.1186/s12879-022-07268-8.
8
High Asymptomatic Carriage With the Omicron Variant in South Africa.南非奥密克戎变异株高无症状携带率。
Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.
9
The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的有效繁殖数相对于德尔塔变异株而言是其数倍。
J Travel Med. 2022 May 31;29(3). doi: 10.1093/jtm/taac037.
10
Quantifying pupil-to-pupil SARS-CoV-2 transmission and the impact of lateral flow testing in English secondary schools.量化学生间 SARS-CoV-2 的传播和侧向流检测在英国中学的影响。
Nat Commun. 2022 Mar 1;13(1):1106. doi: 10.1038/s41467-022-28731-9.